CytoSorbents Corp. (CTSO)
0.7911
+0.04
(+5.62%)
USD |
NASDAQ |
Mar 03, 16:00
0.7911
0.00 (0.00%)
After-Hours: 20:00
CytoSorbents Research and Development Expense (Annual) : 6.916M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Delcath Systems, Inc. | 29.25M |
| Quest Diagnostics, Inc. | -- |
| Danaher Corp. | 1.598B |
| Cardiac Biotech Solutions, Inc. | 0.1732M |
| Odyssey Health, Inc. | 0.00 |